DK62692D0 - - Google Patents


Publication number
DK62692D0 DK62692A DK62692A DK62692D0 DK 62692 D0 DK62692 D0 DK 62692D0 DK 62692 A DK62692 A DK 62692A DK 62692 A DK62692 A DK 62692A DK 62692 D0 DK62692 D0 DK 62692D0
Application number
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK62692A priority Critical patent/DK62692D0/da
Publication of DK62692D0 publication Critical patent/DK62692D0/da
Priority claimed from NO940123A external-priority patent/NO940123L/en


DK62692A 1992-05-14 1992-05-14 DK62692D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK62692A DK62692D0 (en) 1992-05-14 1992-05-14

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
DK62692A DK62692D0 (en) 1992-05-14 1992-05-14
IL10567393A IL105673A (en) 1992-05-14 1993-05-11 Use of n-substituted adenosine derivatives for the preparation of medicaments for treating myocardial or cerebral ischemia, certain novel n-substituted adenosine derivatives and pharmaceutical compositions containing them
EP19930909822 EP0603348A1 (en) 1992-05-14 1993-05-12 Purine derivatives
PCT/DK1993/000158 WO1993023418A1 (en) 1992-05-14 1993-05-12 Purine derivatives
JP51978793A JPH06508855A (en) 1992-05-14 1993-05-12
AU40612/93A AU671995B2 (en) 1992-05-14 1993-05-12 Purine derivatives
CA 2113547 CA2113547A1 (en) 1992-05-14 1993-05-12 Purine derivatives
NZ25211093A NZ252110A (en) 1992-05-14 1993-05-12 Adenosine derivatives and pharmaceutical compositions
FI940167A FI940167A (en) 1992-05-14 1994-01-13 purine
NO940123A NO940123L (en) 1992-05-14 1994-01-13 purine derivatives

Publications (1)

Publication Number Publication Date
DK62692D0 true DK62692D0 (en) 1992-05-14



Family Applications (1)

Application Number Title Priority Date Filing Date
DK62692A DK62692D0 (en) 1992-05-14 1992-05-14

Country Status (9)

Country Link
EP (1) EP0603348A1 (en)
JP (1) JPH06508855A (en)
AU (1) AU671995B2 (en)
CA (1) CA2113547A1 (en)
DK (1) DK62692D0 (en)
FI (1) FI940167A (en)
IL (1) IL105673A (en)
NZ (1) NZ252110A (en)
WO (1) WO1993023418A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK155292D0 (en) * 1992-12-23 1992-12-23 Novo Nordisk As Chemical compounds, their preparation and use
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives
WO1995030683A1 (en) * 1994-05-10 1995-11-16 Sandoz Ltd. Adenosine derivatives
EP0704215A3 (en) * 1994-06-02 1998-04-01 Takeda Chemical Industries, Ltd. Inhibitor of vascular permeability enhancer
GB9421133D0 (en) * 1994-10-20 1994-12-07 Glaxo Group Ltd Medicaments
US6110902A (en) * 1997-06-23 2000-08-29 Moehler; Hanns Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine
CO5180581A1 (en) * 1999-09-30 2002-07-30 Pfizer Prod Inc Compounds for the treatment of ischemia tions containing pharmaceutical for the treatment of ischemia
US6803457B1 (en) 1999-09-30 2004-10-12 Pfizer, Inc. Compounds for the treatment of ischemia
AU6007601A (en) * 2000-05-15 2001-11-26 Novo Nordisk As Compounds for treating disorders where a decreased level of plasma ffa is desired
US7414036B2 (en) 2002-01-25 2008-08-19 Muscagen Limited Compounds useful as A3 adenosine receptor agonists
WO2007107598A1 (en) 2006-03-21 2007-09-27 Heinrich-Heine-Universität Düsseldorf Phosphorylated a2a receptor agonists
CZ2009298A3 (en) * 2009-05-14 2010-11-24 Univerzita Palackého v Olomouci Substituted 6-benzylaminopurine ribosides, their use and pharmaceutical composition in which said compounds are comprised
WO2011085361A1 (en) 2010-01-11 2011-07-14 Inotek Pharmaceuticals Corporation Combination, kit and method of reducing intraocular pressure
JP2013523738A (en) * 2010-03-26 2013-06-17 イノテック ファーマシューティカルズ コーポレイション Adenosine compounds and their use
AU2011230580A1 (en) 2010-03-26 2012-10-11 Inotek Pharmaceuticals Corporation Method of reducing intraocular pressure in humans using N6 -cyclopentyladenosine (CPA), CPA derivatives or prodrugs thereof
PL2807178T3 (en) 2012-01-26 2017-12-29 Inotek Pharmaceuticals Corporation Anhydrous polymorphs of (2r,3s,4r,5r)-5-(6-(cyclopentylamino)-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl) } methyl nitrate and processes of preparation thereof
JP2016513706A (en) 2013-03-15 2016-05-16 イノテック ファーマシューティカルズ コーポレイション Ophthalmic preparations
JP2015172077A (en) * 2015-06-24 2015-10-01 中国医学科学院葯物研究所 Applications of n6-substituted adenosine derivative and n6-substituted adenine derivative to calming, hypnoses, convulsion resistance, epileptic resistance, parkinson disease resistance, and dementia prevention and treatment

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670077C3 (en) * 1966-05-07 1975-04-24 Boehringer Mannheim Gmbh, 6800 Mannheim
NL128629C (en) * 1966-05-07
NL6717061A (en) * 1966-12-21 1968-06-24
DE2052596A1 (en) * 1970-10-27 1972-05-04
DE3406533A1 (en) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh Use of containing these adenosine derivatives as anti-allergic agents and drug,
EP0305643B1 (en) * 1984-04-18 1994-01-05 Whitby Research Incorporated N-6 thienyl substituted adenosine derivatives as cardiac vasodilators
US4791103A (en) * 1985-02-08 1988-12-13 Warner-Lambert Company 2,N6 -disubstituted adenosines, derivatives and methods of use
JPH0696534B2 (en) * 1986-04-25 1994-11-30 ヘキストジヤパン株式会社 Anti-dementia agents
GB8729994D0 (en) * 1987-12-23 1988-02-03 Glaxo Group Ltd Chemical compounds
HUT61567A (en) * 1990-12-07 1993-01-28 Sandoz Ag Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate
DK62592D0 (en) * 1992-05-14 1992-05-14 Novo Nordisk As

Also Published As

Publication number Publication date
WO1993023418A1 (en) 1993-11-25
EP0603348A1 (en) 1994-06-29
AU4061293A (en) 1993-12-13
IL105673D0 (en) 1993-09-22
JPH06508855A (en) 1994-10-06
FI940167A (en) 1994-03-03
NZ252110A (en) 1996-07-26
FI940167A0 (en) 1994-01-13
IL105673A (en) 1998-01-04
AU671995B2 (en) 1996-09-19
FI940167D0 (en)
CA2113547A1 (en) 1993-11-25

Similar Documents

Publication Publication Date Title
JPH05227938K1 (en)
DE9201439U1 (en)
DE9215528U1 (en)
EP0568981A3 (en)
JPH07506983A (en)
JPH07509537A (en)
TW238363B (en)
JPH07502541A (en)
JPH07502946A (en)
JPH07503650A (en)
TW273009B (en)
TW225585B (en)
TW216464B (en)
DE9207289U1 (en)
DE9207837U1 (en)
DE9209416U1 (en)
DE9207407U1 (en)
JPH07503752A (en)
TW238375B (en)
JPH07506829A (en)
DE9200844U1 (en)
JPH07505359A (en)
JPH06509177A (en)
JPH07503345A (en)
TW226396B (en)